Quantbot Technologies’s Albireo Pharma Inc ALBO Stock Holding History

Quantbot Technologies’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$21.6K	–	2224
2022 Q4	$21.6K	Sell	1,000 -5,200	-84%	-$110K	﹤0.01%	1435
2022 Q3	$120K	Buy	6,200 +6,055	+4,176%	+$125K	0.01%	1048
2022 Q2	$2K	Buy	+145	New	+$3.83K	﹤0.01%	1634
2020 Q4	–	Sell	-200	Closed	-$6K	–	1798
2020 Q3	$6K	Buy	+200	New	+$5.83K	﹤0.01%	1176

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quantbot Technologies's ALBO Position: Q1 2023 in Review

Quantbot Technologies sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,000 shares — an estimated $21.6K sold.

Quantbot Technologies first reported a position in ALBO in Q3 2020 and held it in 4 quarters. The position peaked at $120K in Q3 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Quantbot Technologies reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Quantbot Technologies sold 1,000 Albireo Pharma Inc shares in Q1 2023, an estimated $21.6K.
Quantbot Technologies first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 4 quarters.
Quantbot Technologies's Albireo Pharma Inc position peaked at $120K in Q3 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.